Researchers discover how cell membrane composition drives cancer proliferation
Cells are enveloped by a lipid membrane that gives them structure and provides a barrier between the cell…
Targeting IGF2BP2 improves anti-angiogenic therapy effectiveness in colorectal cancer
A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment…
Transcription factor HOXD13 drives melanoma growth and immune evasion
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’…
Palbociclib improves progression-free survival in HER2 positive breast cancer
PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the…
Flexible drug-delivery patch can promote tissue healing after a heart attack
MIT engineers have developed a flexible drug-delivery patch that can be placed on the heart after a heart…
Using placental growth factor to predict preeclampsia risk in pregnant women with sickle cell disease
In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring…
HER2 and CD24 emerge as promising radiotheranostic targets in endometrial cancer
Two molecular targets-human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)-are highly promising candidates for…
Heparanase 2 emerges as key protector of blood vessel integrity
An international research team led by MDI Biological Laboratory President Hermann Haller, M.D. and postdoctoral researcher Yannic Becker,…
UiPath Continues Its Momentum With AI-Powered Automation Growth
UiPath PATH continues to drive value in 2025 through its innovative AI-powered enterprise automation platform, a single defining…